/Companies

Stroke Dx

Culver City, US · Founded 2022 · 8 employees on LinkedIn · 3 known investors

Find your way into Stroke Dx

Sign up to see every warm intro you have to Stroke Dx

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Stroke Dx team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

NeuraNova (formerly StrokeDx) develops non-invasive neurovascular diagnostic technology aimed at rapid detection for stroke and brain-related conditions. Its product is not yet FDA cleared or commercially available.

Founders & leadership

Stroke Dx was founded in 2022 by Alexander Ballatori and Shane Shahrestani.

AB
Alexander BallatoriCofounder30 Under 30 2025
SSShane Shahrestani
Shane ShahrestaniCo-FounderShane Shahrestani is a neurosurgery resident at Cedars-Sinai Medical Center and holds an MD/PhD from USC-Caltech. He is co-founder and Chief Scientific and Innovation Officer at NeuraNova, which develops non-invasive diagnostic technology for detecting stroke and brain-related conditions.30 Under 30 2025

Investors · 3

Also in the syndicate · 1

Freeflow Ventures

Reported raises · per SEC filings

Form D private placements

$6M disclosed across 2 rounds · 2022–2024

▶$4.3MraisedJun 2024 · 3 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Kevin BarrettDirector
  • Alexander BallatoriExecutive Officer, Director
  • Shane ShahrestaniExecutive Officer, Director
Offering amount
$5M
Amount sold
$4.3M
First sale
May 2024
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.7MraisedOct 2022 · 5 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Alexander BallatoriExecutive Officer, Director
  • Shane ShahrestaniExecutive Officer, Director
Offering amount
$2.5M
Amount sold
$1.7M
First sale
Oct 2022
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Stroke Dx do?
NeuraNova (formerly StrokeDx) develops non-invasive neurovascular diagnostic technology aimed at rapid detection for stroke and brain-related conditions. Its product is not yet FDA cleared or commercially available.
Who founded Stroke Dx?
Stroke Dx was founded by Alexander Ballatori, Shane Shahrestani in 2022.
Who are Stroke Dx's investors?
Stroke Dx's investors include DigiTx Partners LLC, FREEFLOW.
How much funding has Stroke Dx raised?
Stroke Dx has disclosed $6M raised across 2 rounds.
Where is Stroke Dx headquartered?
Stroke Dx is headquartered in Culver City, US.